Glucose Level Management in Non-Diabetic Applications

Publication ID: 24-11857763_0007_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Glucose Level Management in Non-Diabetic Applications,” Published Technical Disclosure No. 24-11857763_0007_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857763_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,763.

Summary of the Inventive Concept

This inventive concept leverages the core technology of adjusting insulin delivery rates to manage glucose levels in various non-diabetic applications, including livestock feed optimization, personalized nutrition planning, real-time glucose monitoring in athletes, crop yield optimization, and hypoglycemia prevention in patients undergoing anesthesia.

Background and Problem Solved

The original patent focused on adjusting insulin delivery rates for diabetes management. However, glucose level management is crucial in other fields as well. For instance, in livestock farming, glucose level variations can impact animal health and productivity. Similarly, in athletes, real-time glucose monitoring can improve performance and prevent hypoglycemia. This inventive concept addresses these unmet needs by applying the core technology to new industries and use cases.

Detailed Description of the Inventive Concept

The new claims describe systems and methods that utilize glucose measurement devices, models for predicting future glucose levels, and controllers for adjusting various parameters to minimize glucose level variations. For example, in livestock feed optimization, the system adjusts feed composition to maintain optimal glucose levels. In personalized nutrition planning, the model predicts glucose responses to different meal compositions and selects the optimal meal plan. In real-time glucose monitoring, the device alerts athletes to take corrective action when glucose levels deviate from a target range. Similarly, in crop yield optimization, the system adjusts irrigation and fertilization schedules to minimize glucose level variations in plants. In hypoglycemia prevention, the system alerts medical staff to take corrective action when glucose levels deviate from a target range during anesthesia.

Novelty and Inventive Step

The new claims introduce a novel application of the core technology to non-diabetic fields, providing an inventive step over the original patent. The specific combination of glucose measurement devices, predictive models, and controllers tailored to each new application is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include using different types of glucose measurement devices, such as implantable sensors or non-invasive optical sensors. Variations may also include integrating the glucose level management systems with other technologies, such as machine learning algorithms or IoT devices, to enhance their functionality and accuracy.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including livestock farming, sports and fitness, agriculture, and healthcare. The market size for glucose level management in these industries is substantial, and the inventive concept offers a unique value proposition by providing precise and real-time glucose level management solutions.

CPC Classifications

SectionClassGroup
A A61 A61M5/1723
A A61 A61B5/14532
A A61 A61B5/4839
A A61 A61M5/142
A A61 A61M5/145
A A61 A61M5/14244
A A61 A61M5/14248
G G16 G16H20/17
G G16 G16H40/60
G G16 G16H40/67
A A61 A61B2562/0295
A A61 A61M2005/14208
A A61 A61M2205/3303
A A61 A61M2205/3553
A A61 A61M2205/3561
A A61 A61M2205/3569
A A61 A61M2205/3584
A A61 A61M2205/502
A A61 A61M2205/52
A A61 A61M2230/005
A A61 A61M2230/201
G G16 G16H10/60
G G16 G16H40/40
G G16 G16H50/30

Field of Art

Medical device technology and metabolic monitoring systems, specifically focused on glucose level management, insulin delivery, and predictive health monitoring. Requires expertise in biomedical engineering, sensor technologies, data modeling, and physiological parameter tracking

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with advanced degrees in bioengineering, electrical engineering, or medical informatics. Possesses knowledge of glucose measurement technologies, predictive modeling techniques, and interdisciplinary applications of metabolic monitoring systems

Obviousness Rationale

A PHOSITA would recognize that the core technological framework of glucose level prediction and parameter adjustment from the source patent can be systematically translated across multiple domains. The fundamental principles of measuring glucose levels, predicting future values, and implementing corrective interventions are universally applicable, making the PTD's variations predictable extensions of the original technological concept.

Obvious Combinations & Variations

Source Patent Element
Method for calculating probability of achieving glucose levels and adjusting insulin delivery
PTD Variation
Applying the same probabilistic modeling and intervention approach to livestock feed optimization
Obviousness Reasoning
Known technique of transferring predictive control systems across biological domains, with predictable results in managing metabolic parameters
Source Patent Element
Obtaining fear of hypoglycemia index and receiving glucose data
PTD Variation
Implementing similar indexing and data collection methods for athletic performance monitoring
Obviousness Reasoning
Predictable application of existing glucose monitoring techniques to a different physiological context with finite, identifiable solutions
Source Patent Element
Calculating plurality of future glucose values across multiple delivery profiles
PTD Variation
Extending modeling approach to crop yield optimization and plant metabolic management
Obviousness Reasoning
Obvious design choice to adapt existing predictive modeling techniques to plant biological systems using known scientific principles
Source Patent Element
Systems for tracking and responding to glucose level variations
PTD Variation
Creating alarm systems for medical staff during anesthesia to prevent hypoglycemic events
Obviousness Reasoning
Known medical monitoring technique of translating glucose tracking technologies to patient safety interventions
Source Patent Element
Insulin delivery rate adjustment based on probabilistic modeling
PTD Variation
Personalized nutrition planning using glucose response prediction
Obviousness Reasoning
Predictable extension of metabolic modeling techniques to nutritional optimization with finite, scientifically grounded approaches
35 U.S.C. § 103 Summary: Based on US Patent 11857763's comprehensive disclosure of glucose level management methodologies, the present publication demonstrates that the claimed variations represent obvious technological extensions readily apparent to a person having ordinary skill in the art. The systematic application of glucose monitoring, predictive modeling, and intervention strategies across multiple domains constitutes prima facie obviousness under 35 U.S.C. ยง 103, rendering potential patent claims covering such variations unpatentable as anticipated prior art.

Original Patent Information

Patent NumberUS 11,857,763
TitleAdjusting insulin delivery rates
Assignee(s)INSULET CORPORATION